• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT HAVAB-IGM; HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT HAVAB-IGM; HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY) Back to Search Results
Catalog Number 06C30-74
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/17/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 6c30 that has a similar product distributed in the us, list number 6l21.
 
Event Description
The customer reported a false non-reactive architect (b)(6) result on a (b)(6) yr old male patient.Results provided: on (b)(6) 2020 sid (b)(6) = 0.5 s/co, wantai manual method = positive.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for a false non-reactive result for one sample tested with the architect havab igm assay lot 10346be01 included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review.Inhouse retained kit testing for sensitivity could not be performed as reagent lot had been expired when complaint investigation was performed.Trending review determined no trends for the issue for the product.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.Based on our investigation, no systemic issue or deficiency with the architect havab igm reagent lot 10346be01 was identified in the complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-IGM
Type of Device
HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY)
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10566075
MDR Text Key233891661
Report Number3002809144-2020-00980
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 12/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/28/2020
Device Catalogue Number06C30-74
Device Lot Number10346BE01
Was Device Available for Evaluation? No
Date Manufacturer Received12/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(4); ARCHITECT I2000SR ANALYZER LIST 03M74-02; SERIAL (B)(4)
Patient Age53 YR
-
-